| |
| |
| |
|
 |
P.
Anthony Rhatigan
Chairman |
| |
Mr
Rhatigan has been a director of a number of public companies
listed in London, Vancouver and Toronto and has extensive
international experience in many fields including construction,
commercial and residential property investment and development,
stone quarrying, asphalt manufacturing, mining and mineral
exploration. Mr Rhatigan is Vice Chairman, non-executive,
of Manor River Resources Inc., a Canadian company whose
shares are quoted on the Toronto Venture Exchange and
on AIM and is Chairman of its Audit Committee and also
of its Remunition Committee. |
| |
 |
James
Heffernan PhD
Chief Executive Officer |
| |
Dr
Heffernan has over 20 years experience in the global
life science market and joined NextGen Sciences from
Upstate Ltd, where he held the position of Managing
Director, Europe. Previously Dr Heffernan set up and
ran Northern European operations for Promega, a major
US biotechnology company, then ran the North American
commercial operations. He has also held senior executive
positions with Sigma-Aldrich Corp, USA and Celltech,
UK. Dr Heffernan has a BSc and PhD in Chemistry from
Strathclyde University. |
| |
 |
Frank
Matthäi
Chief
Financial Officer |
| |
Frank
Matthäi started his business career as an independent
consultant to entrepreneurs who were establishing new
businesses.
In the early 1990 he became managing partner of Ponton,
an innovative group working in the field of interactive
media. With his partners he developed the company to
a group with three divisions: software developing, strategic
consultancy and interactive media. In addition they
developed a portfolio of innovative companies in which
they held a minority stake. Since the end of 2001 Mr.
Matthäi has been an independent consultant for
small and midcap technology companies. His main areas
of focus are the financial, administration and strategic
functions. Mr.
Matthäi has wide experience as a CFO and in the
acquisition of and management of companies. |
|
|
| |
|
|
| |
|
|
| |
Note:
The stock price performance shown on the quote above is not
necessarily indicative of future price performance. |
|
| |
|
|
| |
|
|
| |
|
| |
|
|
| |
 |
|
| |
For
more information please contact>
James
Heffernan
t: +44 (0) 1480 410 979
f: +44 (0) 1480 410 858
e: james.heffernan@nextgensciences.com
|
|
|